Development of a hybrid artificial liver support system and preclinical animal experiments

Journal of Artificial Organs

Volumn 3, Issue 2, 2000, Pages 112-116

  Ijima, Hiroyuki ^a   Nakazawa, Kohji ^a   Kaneko, Mitsuru ^a   Fukuda, Junji ^a   Shimada, Mitsuo ^b   Yamashita, Yo Ichi ^b   Gion, Tomonobu ^b   Shirabe, Ken ^b   Sugimachi, Keizo ^b   Fumatsu, Kazumori ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Hepatocyte; Hybrid artificial liver; Polyurethane foam; Preclinical animal experiment; Spheroid

Indexed keywords

AMMONIA; COLLAGEN; DEXTRAN; GLUCOSE;

AMMONIA BLOOD LEVEL; ANIMAL CELL; ARTIFICIAL LIVER; BIOREACTOR; CELL CULTURE; GLUCOSE BLOOD LEVEL; HEPATITIS; HUMAN; INFECTION RISK; LIVER CELL; LIVER FAILURE; NONHUMAN; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; SPHEROID CELL; SWINE; VIRUS INFECTION;

EID: 0034537910     PISSN: 14347229     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02479976     Document Type: Review

References (49)

1. The fourth barrier
2. Xenotransplantation: A potential solution to the critical organ donor shortage
3. Fractionated plasma separation and adsorption system: A novel system for blood purification to remove albumin bound substances
4. Molecular adsorbent recycling system (MARS): Clinical results of a new membrane-based blood purification system for bioartificial liver support
5. Temporary extracorporeal liver support for severe acute alcoholic hepatitis using the BioLogic-DT
6. Cytokines and endotoxin removal by sorbents and its application in push-pull sorbent-based pheresis: The biologic-DTPF system
7. Examination of 7-ethoxycoumarin deethylation and ammonia removal activities in 31 hepatocyte cell lines
8. Comparison of different hepatocyte cell lines for use in a hybrid artificial liver model
9. Construction of ammonia metabolizing cell line for artificial hybrid liver support system using recombinant DNA techniques
10. Characterization and evaluation of detoxification functions of a nontumorigenic immortalized porcine hepatocyte cell line (HepLiu)
11. The hepatic extracorporeal liver assist device: Initial clinical experience
12. Development of a hybrid artificial liver
13. Modulation of immunologic reactions between cultured porcine hepatocytes and human sera
14. Clinical experience with a bioartificial liver in the treatment of severe liver failure: A phase I clinical trial
15. Hemodynamic effects of therapy with a hybrid liver support system
16. Novel bioartificial liver support system (BLSS): Clinical experience
17. Prolonged lidocaine metabolizing activity of primary hepatocytes with spheroid culture using polyurethane foam as a culture substratum
18. Potential use of genetically modified pigs as organ donors for transplantation into humans
19. Nonenzymatic versus enzymatic hepatocyte isolation from pig livers for larger scale investigations of liver cells perfusion systems
20. A large scale isolation of pig hepatocytes for a bioartificial liver support system
21. Hybrid artificial liver
22. Continued high albumin production by multicellular spheroids of adult rat hepatocytes formed in the presence of liver-derived proteoglycans
23. High albumin production by multicellular spheroids of adult rat hepatocytes formed in the pores of polyurethane foam
24. Tissue engineering
25. Tissue engineering - Toward new solutions for transplantation and reconstructive surgery
26. Polymer concepts in tissue engineering
27. The effect of donor and recipient age on engraftment of tissue-engineered liver
28. European research and commercialization activities in the field of tissue engineering and liver support in world wide competition
29. Enhanced cytochrome P450IA1 activity of self-assembled rat hepatocyte spheroids
30. Formation of a spherical multicellular aggregate (spheroid) of animal cells in the pores of polyurethane foam as a cell culture substratum and its application to a hybrid artificial liver
31. Hepatocyte spheroids in polyurethane foams: Functional analysis and application for a hybrid artificial liver
32. Formation of porcine hepatocyte spherical multicellular aggregates (spheroid) and analysis of drug metabolic functions
33. The formation of a spheroid of primary hepatocytes and the expression of liver-specific functions depend on the characteristics of polyurethane foam
34. Investigation of optimum culture condition for hybrid artificial liver module using PUF/porcine hepatocyte spheroid culture
35. Stable immobilization of hepatocyte spheroids rapidly formed by large-scale suspension culture
36. Development of a hybrid artificial liver using multi capillary PUF/spheroid packed bed
37. A hybrid bioartificial liver composed of multiplated hepatocyte monolayers
38. Development of a bioartificial liver: Properties and function of a hollow-fiber module inoculated with liver cells
39. A bioartificial liver to treat severe acute liver failure
40. Bioartificial liver support system using porcine hepatocytes entrapped in a three-dimensional hollow fiber module with collagen gel: An evaluation in the swine acute liver failure model
41. Estimation of the performance of a PUF/spheroid packed-bed type artificial liver by using an extracorporeal circulation with hepatic failure rats
42. Spheroid formation of primary dog hepatocytes using polyurethane foam and its application to hybrid artificial liver
43. Evaluation of a hybrid artificial liver using a polyurethane foam packed-bed culture system in dogs
44. Development of hybrid artificial liver support system using spheroid culture and application to warm ischemic liver failure in dog and pig as a preclinical test
45. Preclinical animal experiment of a hybrid artificial liver
46. Infection of human cells by an endogenous retrovirus of pigs
47. FDA subcommittee finds no evidence of PERV transmission
48. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue
49. Evidence of absence of porcine endogenous retrovirus (PERV) infection in patients treated with a bioartificial liver support system